Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh

Int J Antimicrob Agents. 2004 Nov;24(5):508-10. doi: 10.1016/j.ijantimicag.2004.05.007.

Abstract

The prevalence of extended-spectrum beta-lactamases (ESBL)-producing organisms in an urban hospital in Dhaka City was assessed over a 10-month period. A double disk test was performed to detect ESBL-producing Escherichia coli and Klebsiella pneumoniae. 43.2% and 39.5% of E. coli and K. pneumoniae had ESBL phenotypes, respectively. The combination of augmentin with ceftazidime detected the most ESBL-producing E. coli (39.5%) while augmentin with ceftriaxone was the best combination for the detection of ESBL (31.6%) in K. pneumoniae.

MeSH terms

  • Amoxicillin-Potassium Clavulanate Combination / pharmacology
  • Bangladesh / epidemiology
  • Ceftazidime / pharmacology
  • Ceftriaxone / pharmacology
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology*
  • Escherichia coli / genetics
  • Escherichia coli / isolation & purification
  • Female
  • Hospitals, Urban
  • Humans
  • Klebsiella / drug effects
  • Klebsiella / enzymology*
  • Klebsiella / genetics
  • Klebsiella / isolation & purification
  • Male
  • Microbial Sensitivity Tests
  • Prevalence
  • beta-Lactam Resistance
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • Amoxicillin-Potassium Clavulanate Combination
  • Ceftriaxone
  • Ceftazidime
  • beta-Lactamases